FEMCON Fe (Allergan, Inc.)
Welcome to the PulseAid listing for the FEMCON Fe drug offered from Allergan, Inc.. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Allergan, Inc. |
| NON-PROPRIETARY NAME: | norethindrone and ethinyl estradiol, and ferrous fumarate |
| SUBSTANCE NAME: | |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | |
| ROUTE: | |
| DOSAGE FORM: | KIT |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2006-11-01 |
| END MARKETING DATE: | 0000-00-00 |
FEMCON Fe HUMAN PRESCRIPTION DRUG Details:
| Item Description | FEMCON Fe from Allergan, Inc. |
| LABELER NAME: | Allergan, Inc. |
| DEA SCHEDULE: | |
| ACTIVE STRENGTH: | () |
| START MARKETING DATE: | 2006-11-01 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0023-5970_83697cee-7db6-4b24-a606-7ee2cf757157 |
| PRODUCT NDC: | 0023-5970 |
| APPLICATION NUMBER: | NDA021490 |